从不吸烟者小细胞肺癌的临床与基因组特征:回顾性多中心队列研究
从不吸烟者较吸烟者更多为女性(66.0% vs 52.4%,P=.009)和广泛期(70.0% vs 62.2%,P=.028),35-49岁(7.0% vs 3.0%,P=.006)及≥80岁(17.0% vs 8.2%,P=.006)比例更高,但总生存无差异;9例基因组数据分析显示从不吸烟者肿瘤突变负荷更低、TP53突变频率更低且无烟草暴露相关突变特征。
要点
- 从不吸烟者占小细胞肺癌的1.8%,女性及广泛期比例更高。
- 从不吸烟者年龄分布呈35-49岁和≥80岁双峰,已知肺癌风险因素<20%。
- 从不吸烟者与吸烟者总生存无差异,但基因组特征提示不同生物学。
核心结论
- 从不吸烟者小细胞肺癌在性别和年龄分布上不同于吸烟者,基因组分析提示其生物学特征与吸烟者不同。
研究设计与样本
- 回顾性多中心队列研究,使用纵向全国代表性电子病历数据库,纳入5,632例临床确诊小细胞肺癌患者。
- 吸烟史通过技术辅助提取评估,从不吸烟者经病历复核确认。
- 对从不吸烟者小细胞肺癌采用基于下一代测序的基因面板和全外显子测序分析基因组特征。
主要发现
- 从不吸烟者较吸烟者更可能为女性(66.0% vs 52.4%;P=.009)和广泛期(70.0% vs 62.2%;P=.028)。
- 从不吸烟者在35-49岁年龄组比例更高(7.0% vs 3.0%;P=.006),≥80岁年龄组比例也更高(17.0% vs 8.2%;P=.006)。
- 从不吸烟者中已知肺癌风险因素发现率<20%。
- 从不吸烟者与吸烟者总生存无差异。
临床怎么用
- 临床遇到从不吸烟的小细胞肺癌患者应关注其女性、广泛期及特定年龄分布特征。
- 对从不吸烟者小细胞肺癌可考虑基因组分析以识别独特生物学特征。
局限性
- 基因组分析仅纳入9例患者,样本量小。
- 回顾性研究设计可能存在选择偏倚和信息偏倚。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Small cell lung cancer (SCLC) has the strongest association with smoking among lung cancers. The characteristics of never smokers with SCLC is not known. RESEARCH QUESTION: Are the clinical characteristics, prognostic factors, survival, genomic alterations, and tumor mutational burdens of SCLC in patients who have never smoked different from those who have smoked? STUDY DESIGN AND METHODS: A retrospective multicenter cohort study of patients with clinician-confirmed SCLC was performed with the use of a longitudinal and nationally representative electronic medical records database. Smoking history was assessed through technology-enabled abstraction and confirmed for never smokers via chart review. Genomic characteristics of never smoker patients with SCLC were examined with the use of a next-generation sequencing-based gene panel and whole exome sequencing. RESULTS: One hundred of 5,632 patients (1.8%) with SCLC were never smokers. Relative to smokers, never smokers were more likely to be female (66.0% vs 52.4%; P = .009) and present with extensive stage (70.0% vs 62.2%; P = .028). Never smokers had a higher proportion of patients in age groups 35 to 49 years (7.0% vs 3.0%; P = .006) and ≥80 years (17.0% vs 8.2%; P = .006). Known risk factors for lung cancer were found in <20% of never smokers. There were no overall survival differences between never smokers and smokers. Among patients with available genomic data (n = 9), never smoker SCLC were characterized by lower tumor mutational burden, a lower frequency of TP53 mutations, and an absence of mutational signatures related to tobacco exposure. INTERPRETATION: The sex- and age-specific distribution of SCLC among never smokers, along with differences that were identified by genomic analyses, suggests a distinct biology of SCLC in never smokers compared with smokers.
引用
- Thomas A, Mian I, Tlemsani C, et al. Clinical and Genomic Characteristics of Small Cell Lung Cancer in Never Smokers: Results From a Retrospective Multicenter Cohort Study. Chest. 2020. PMID: 32464188. doi:10.1016/j.chest.2020.04.068
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。